GPC3 and hepatocellular carcinoma: The expression levels of several exosomal proteins, including carcinoembryonic antigen (CEA), GPC-3, PD-L1 and HER2, have been used in combination to identify healthy individuals, hepatitis B patients, and HCC patients [146].